| 摘要 |
<p>The invention relates to a method of preventing or treating a disease related to the 5-HT2C receptor and the 5-HT6 receptor, comprising administering to a human or animal subject in need thereof a 5-HT2C receptor agonist and a 5-HT6 receptor antagonist in sufficient amounts to provide a therapeutic affect. The invention also relates to a pharmaceutical composition comprising an effective amount of a combination of a 5-HT¿2C receptor agonist and a 5-HT¿6? receptor antagonist, and optionally a pharmaceutically acceptable carrier.</p> |
